Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,336 result(s) found. Displaying page 633 of 2,217.
    «« First « Previous 629  630  631  632  633  634  635  636  637  Next» Last»»
    EudraCT Number: 2005-005402-22 Sponsor Protocol Number: GT-11 Start Date*: 2006-02-08
    Sponsor Name:ALK-Abelló A/S
    Full Title: A randomised, double-blind, placebo-controlled, multi-centre Phase I Trial investigating the safety of GRAZAX-R in children aged 5-12 years with grass pollen induced rhinoconjunctivitis (with/witho...
    Medical condition: IgE mediated allergy (hay fever, rhinoconjunctivitis) to grass pollen (Timothy grass, Phleum pratense) with or without asthma
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005422-31 Sponsor Protocol Number: COX189A2425 Start Date*: 2006-05-05
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A 16-day, randomized, double-blind, double-dummy, placebo-controlled, parallel-group trial comparing lumiracoxib 100mg o.d. with naproxen 500 mg b.i.d. plus omeprazole 20mg o.d. and placebo in heal...
    Medical condition: Healthy volunteers.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-005728-17 Sponsor Protocol Number: HOP LITE Start Date*: 2006-11-02
    Sponsor Name:AZIENDA PROVINCIALE PER I SERVIZI SANITARI DELLA PROVINCIA AUTONOMA DI TRENTO
    Full Title: Hormone-refractory Prostate cancer first Line Intermittent Taxotere and Estramustine.
    Medical condition: Prostate cancer.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10036909 PT
    Population Age: Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002198-32 Sponsor Protocol Number: 11394 Start Date*: 2008-01-14
    Sponsor Name:Biomet NL
    Full Title: Prospective randomized study of the effect of autologous concentrated thrombocytes versus corticosteroid injections in lateral epicondylitis.
    Medical condition: Tenniselbow, also known as lateral epicondylitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003122-28 Sponsor Protocol Number: ArgLepi-2006 Start Date*: 2008-12-19
    Sponsor Name:Heinrich-Heine-Universität Düsseldorf
    Full Title: Argatroban versus Lepirudin in Critically Ill Patients
    Medical condition: Critically ill patients are usually treated with heparin for anticoagulation. A serious complication of heparin therapy is heparin-induced thrombocytopenia type II (HIT). Patients with HIT have t...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10062506 Heparin-induced thrombocytopenia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003123-37 Sponsor Protocol Number: Start Date*: 2006-10-12
    Sponsor Name:University Hospital Sint Radboud
    Full Title: Treatment with high dose Methotrexate in patients with eosinophilic fasciitis
    Medical condition: Eosinophilic fasciitis (EF) is a skin disorder involving the deep fascia, resulting in pain and swelling of extremities, cutaneous induration and joint contractures. Most patients require therapy. ...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003139-65 Sponsor Protocol Number: Start Date*: 2007-01-10
    Sponsor Name:Medway NHS Trust
    Full Title: The effect of clonidine on desflurane consumption using BIS monitoring.
    Medical condition: Depth of anaesthesia. Consumption of volatile anaesthetic agent.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10018060 General anaesthesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003577-24 Sponsor Protocol Number: 1018 Start Date*: 2004-12-10
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: remifentanil in continuos infusion as a labour analgesic
    Medical condition: analgesia in partum
    Disease: Version SOC Term Classification Code Term Level
    6.1 10059204 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-002332-17 Sponsor Protocol Number: RL06/7640 Start Date*: 2007-04-18
    Sponsor Name:The Leeds Teaching Hospitals NHS Trust
    Full Title: Prospective, randomised trial comparing the use of Tisseel versus no fibrin sealant in preventing postoperative fluid complications following liver resection
    Medical condition: Patients who are undergoing liver resection. The surgery can be performed for any reason: usually primary or secondary carcinoma but may be performed for other non malignant abnormality or liver di...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-002339-26 Sponsor Protocol Number: E2007-G000-303 Start Date*: 2006-10-05
    Sponsor Name:Eisai Limited
    Full Title: A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients with Motor ...
    Medical condition: Levodopa treated Parkinson's disease patients with motor fluctuations.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed) EE (Completed) CZ (Completed) HU (Completed) BE (Completed) SE (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) DE (Completed) ES (Completed) PT (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-002354-30 Sponsor Protocol Number: ATS K019 / D-Pio-109 Start Date*: 2006-07-27
    Sponsor Name:Takeda Pharma GmbH
    Full Title: Effect of Acute Insulin Intervention followed by Pioglitazone and Metformin Treatment on Metabolic Parameters in Type 2 Diabetic Patients with inadequate Metabolic Control
    Medical condition: Diabetes Type 2
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-002933-18 Sponsor Protocol Number: COPDIT Start Date*: 2007-11-05
    Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH
    Full Title: Multizentrische, randomisierte, doppelblinde, placebokontrollierte Phase III-Studie zur (Langzeit-) Add On-Behandlung der COPD (Schweregrad III/IV) mit 2 x 80 mg inhalativem Tobramycin (Gernebcin)
    Medical condition: Austherapierte schwere bis sehr schwere COPD (Schweregrad III-IV) mit mindestens 2 COPD-Exazerbations-bedingten Hospitalisationen innerhalb der letzten 12 Monate
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010952 COPD LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003225-87 Sponsor Protocol Number: CFOR258D2201 Start Date*: 2007-01-31
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, multi-centre, double-blind, double dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 µg of formoterol delivered by Concept1 has a bronchodilator effi...
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    8.1 10003553 Asthma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003255-20 Sponsor Protocol Number: CRAD001C2241 Start Date*: 2006-11-23
    Sponsor Name:NOVARTIS FARMA
    Full Title: A single arm, multicenter phase II study of RAD001 in patients with metastatic colorectal adenocarcinoma whose cancer has progressed despite prior therapy with an anti-EGFR antibody (if appropriate...
    Medical condition: metastatic colorectal adenocarcinoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10051925 Intestinal adenocarcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-003264-65 Sponsor Protocol Number: sm2006msd01 Start Date*: 2007-01-22
    Sponsor Name:University of Dundee
    Full Title: A Proof-of-Concept Study to evaluate the benefit from add-on therapy with montelukast versus salmeterol in children with asthma carrying the Arg/Arg-16 beta2-receptor genotype
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    8.1 10003553 Asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-000754-40 Sponsor Protocol Number: TUD-CLOPIS-009 Start Date*: 2007-02-28
    Sponsor Name:Dresden University of Technology
    Full Title: Interaktion von Statinen mit Clopidogrel als Sekundärprophylaxe bei der akuten zerebralen Ischämie - CLOPISTAT
    Medical condition: transitoric ischemic attack or cerebral ischemia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000757-21 Sponsor Protocol Number: P04823 Start Date*: 2006-08-15
    Sponsor Name:AESCA Pharma GmbH
    Full Title: Study to evaluate Response Rates in CHC Patients genotype 1 with Insulin Resistance and to assess prolonged Treatment Duration in late virological Responders
    Medical condition: chronic hepatitis C, genotype 1
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000770-75 Sponsor Protocol Number: CE 14/05 CEREA-DES Start Date*: 2005-11-01
    Sponsor Name:AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA
    Full Title: Cortisone Eliminates Restenosis as Effectively As DES
    Medical condition: To assess the clinical efficacy and safety of the prednisone therapy after PCI as a low-tech low-cost systemic alternative to currently available BMS and DES.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10056489 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001169-40 Sponsor Protocol Number: 107192, 107214 Start Date*: 2006-04-19
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: A phase IIb, controlled, randomised, multicenter, observer blinded study to demonstrate the lot-to-lot consistency of three consecutive production lots of low dose of influenza vaccine adjuvanted w...
    Medical condition: Immunization against influenza in male and female subjects aged 60 years and older
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: GB (Completed) EE (Completed) DE (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2006-005854-61 Sponsor Protocol Number: ABPARO Start Date*: 2008-02-15
    Sponsor Name:University Hospital Muenster
    Full Title: Adjunctive antimicrobial therapy of periodontitis: Long-term effects on disease progression and oral microbiological colonization
    Medical condition: periodontal disease (moderate to severe)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10034539 Periodontitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 629  630  631  632  633  634  635  636  637  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 18 08:20:55 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA